» Authors » Yongxia Chen

Yongxia Chen

Explore the profile of Yongxia Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 1358
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang J, Aishan N, Zheng Z, Ju S, He Q, Meng Q, et al.
Epigenetics . 2025 Feb; 20(1):2473250. PMID: 40014756
Breast cancer is the most common cancer among women, with differences in clinical features due to its distinct molecular subtypes. Current studies have demonstrated that epigenetic modifications play a crucial...
2.
Duan X, Shao Y, Zhao S, Zhang Z, Chen Y, Wang F, et al.
Support Care Cancer . 2024 Dec; 33(1):62. PMID: 39739046
Purpose: Based on a dyadic perspective, the interaction between two variables of dyadic coping and post-traumatic growth in couples with breast cancer is explored, which facilitates an empirical basis for...
3.
Jia Y, Chen Y, Chen M, He M, Xu S, Li H, et al.
Cancer Lett . 2024 Dec; 611():217423. PMID: 39736453
Triple-negative breast cancer (TNBC) represents the most aggressive subtype of breast cancer, lacking effective targeted therapies and presenting with a poor prognosis. In this study, we utilized the epigenomic landscape,...
4.
Yu J, Chen Y, Pan X, Chen J, Mai Z, Zhang Y, et al.
J Inflamm Res . 2024 Nov; 17:7869-7879. PMID: 39494206
Purpose: The early diagnosis of septic cardiomyopathy remains a challenge. The present work aims to evaluate the diagnostic and prognostic value of plasma soluble triggering receptor expressed on myeloid cells-1...
5.
Chen Y, Cen K, Wang L, Ruan J, Jia Y
Mol Biomed . 2024 Oct; 5(1):41. PMID: 39358626
No abstract available.
6.
Chen Y, Mao L, Liu S, Huang S, Lin Q, Zeng M, et al.
J Cell Physiol . 2024 Sep; 239(12):e31445. PMID: 39344989
Septic cardiomyopathy (SCM) is an acute cardiac dysfunction involving myocardial cell pyroptosis. TREM-1 is a known receptor on cell membrane that can amplify the inflammatory response. Our previous studies have...
7.
Zhu H, Liu Q, Meng Q, Zhang L, Ju S, Lang J, et al.
J Exp Clin Cancer Res . 2024 Aug; 43(1):245. PMID: 39210442
Sorafenib is widely used in treating advanced hepatocellular carcinoma (HCC). However, its effectiveness in prolonging patient survival is limited by the development of drug resistance. To systematically investigate the resistance...
8.
Mao L, Liu S, Chen Y, Huang H, Ding F, Deng L
Front Cardiovasc Med . 2024 Jul; 11:1399738. PMID: 39006168
Septic cardiomyopathy, a life-threatening complication of sepsis, can cause acute heart failure and carry a high mortality risk. Current treatments have limitations. Fortunately, engineered exosomes, created through bioengineering technology, may...
9.
Zhou Q, Yu H, Chen Y, Ren J, Lu Y, Sun Y
Proc Natl Acad Sci U S A . 2024 Jul; 121(28):e2320655121. PMID: 38959043
SLC7A11 is a cystine transporter and ferroptosis inhibitor. How the stability of SLC7A11 is coordinately regulated in response to environmental cystine by which E3 ligase and deubiquitylase (DUB) remains elusive....
10.
Sun T, Wang M, Li X, Chen Y, Zhang W
Plants (Basel) . 2024 Jun; 13(12). PMID: 38931092
Flooding stress is an increasingly serious problem in wetlands, often affecting large areas of crops and timber production areas. The current study aimed to explore the species differences in responses...